sglt2 inhibitors vs glp 1 agonists Blood Pressure-Lowering Effects of and GLP-1 Receptor https://link.springer.com/article/10.1007/s11906-025-01342-7 Complementary Yet Distinct Roles of

1 Introduction In the past decade, obesity and related co-morbidities have become critical public health problems and serious medical conditions worldwide (1)

Taking GLP-1 medication is just one part of the equation

Retatrutide Strength: 10 mg A premium metabolic-focused option commonly requested in body composition conversations

While Im excited that patients may soon have more options, enthusiasm should not blind us to the risks

Additionally, obesity in early adults has been linked to a substantially increased risk of CD onset in the elderly (84)

If Phase 3 results confirm its safety and efficacy, it could reach the market within the next 12 years